Contravisory Investment Management Inc. Sells 2,081 Shares of The Procter & Gamble Company (NYSE:PG)

Contravisory Investment Management Inc. trimmed its position in The Procter & Gamble Company (NYSE:PG) by 59.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,433 shares of the company’s stock after selling 2,081 shares during the quarter. Contravisory Investment Management Inc.’s holdings in Procter & Gamble were worth $248,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the company. HighPoint Advisor Group LLC acquired a new position in shares of Procter & Gamble in the fourth quarter valued at about $17,696,000. Steele Capital Management Inc. acquired a new position in shares of Procter & Gamble during the 1st quarter worth approximately $204,000. United Advisor Group LLC bought a new position in shares of Procter & Gamble during the fourth quarter worth approximately $3,463,000. GAMMA Investing LLC boosted its stake in shares of Procter & Gamble by 67.2% in the second quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock valued at $4,420,000 after buying an additional 10,777 shares during the period. Finally, Consilio Wealth Advisors LLC grew its position in Procter & Gamble by 27.7% during the first quarter. Consilio Wealth Advisors LLC now owns 1,746 shares of the company’s stock worth $283,000 after buying an additional 379 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares in the company, valued at $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Procter & Gamble news, CEO Jon R. Moeller sold 37,240 shares of the stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the completion of the sale, the chief executive officer now directly owns 263,537 shares in the company, valued at approximately $44,508,763.93. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the transaction, the insider now directly owns 11,537 shares in the company, valued at $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 383,194 shares of company stock valued at $65,140,718. 0.17% of the stock is currently owned by company insiders.

Procter & Gamble Stock Performance

Shares of PG stock opened at $171.09 on Friday. The firm has a market capitalization of $403.80 billion, a price-to-earnings ratio of 27.96, a PEG ratio of 3.67 and a beta of 0.41. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The business’s 50-day moving average price is $171.48 and its 200-day moving average price is $166.74. The Procter & Gamble Company has a 12 month low of $141.66 and a 12 month high of $177.94.

Procter & Gamble (NYSE:PG) last posted its earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, topping the consensus estimate of $1.37 by $0.03. The business had revenue of $20.53 billion for the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The firm’s revenue was down .1% compared to the same quarter last year. During the same period last year, the company earned $1.37 EPS. Equities research analysts forecast that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.35%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio is currently 65.69%.

Analyst Ratings Changes

PG has been the subject of a number of recent analyst reports. TD Cowen assumed coverage on Procter & Gamble in a research report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 target price for the company. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. DA Davidson initiated coverage on shares of Procter & Gamble in a report on Wednesday. They issued a “neutral” rating and a $159.00 target price on the stock. Jefferies Financial Group downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating and cut their price target for the stock from $182.00 to $175.00 in a report on Wednesday, July 24th. Finally, Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Ten equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $175.05.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.